Biomarkers as Predictive Tools in Toxicity Testing

This is the report of the fortieth of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). ECVAM’s main goal, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which are of importance to the biosciences and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures which would enable it to become wellinformed about the state-of-the-art of non-animal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which small groups of invited experts would review the current status of various types of in vitro tests and their potential uses, and make recommendations about the best ways forward (1). In addition, other topics relevant to the Three Rs concept of alternatives to animal experiments have been considered in several ECVAM workshops. This ECVAM workshop on Biomarkers as Predictive Tools in Toxicity Testing was held in Burnham Market (Norfolk, UK) on 5–8 October 1998, under the co-chairmanship of Diane Benford (University of Surrey, UK) ATLA 28, 119–131, 2000 119

[1]  B. Hulka,et al.  Biological markers in epidemiologic research. , 1988, Archives of environmental health.

[2]  K. Setchell,et al.  Dietary isoflavones: biological effects and relevance to human health. , 1999, The Journal of nutrition.

[3]  D. Byar,et al.  The study of markers of biological effect in cancer prevention research trials , 1992, International journal of cancer.

[4]  J. Wahrendorf Design of studies for validation of biomarkers of exposure and their effective use in environmental epidemiology. , 1995, Toxicology.

[5]  J. Angerer,et al.  Report on the status of the external quality-control programs for occupational-medical and environmental-medical toxicological analyses in biological materials in Germany , 1999, International archives of occupational and environmental health.

[6]  Krys Bottrill,et al.  The Use of Biomarkers as Alternatives to Current Animal Tests on Food Chemicals 1 , 1998, Alternatives to laboratory animals : ATLA.

[7]  P. Schulte,et al.  Validation of biological markers for quantitative risk assessment. , 1991, Environmental health perspectives.

[8]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[9]  T. van Gent,et al.  The cholesterol-raising diterpenes from coffee beans increase serum lipid transfer protein activity levels in humans. , 1997, Atherosclerosis.

[10]  P. Kinney,et al.  Application of reliability models to studies of biomarker validation. , 1994, Environmental health perspectives.

[11]  D. Hattis Use of biological markers and pharmacokinetics in human health risk assessment. , 1991, Environmental health perspectives.

[12]  P Grandjean,et al.  Biomarkers in epidemiology. , 1995, Clinical chemistry.

[13]  A. Constable,et al.  The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. , 1998, Carcinogenesis.

[14]  B. Heinzow,et al.  Biomarkers in epidemiological and toxicological nutrition research , 1997 .

[15]  S. Thorgeirsson,et al.  Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. , 1974, Pharmacology.

[16]  J. A. Bond,et al.  The use of biological markers in toxicology. , 1989, Critical reviews in toxicology.

[17]  J. Ward,et al.  Identification of needs in biomarker research. , 1996, Environmental health perspectives.

[18]  Philip J. Landrigan,et al.  Biological markers in environmental health research , 1987 .

[19]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.